Manjulika Das. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Breast Neoplasms/drug therapyBreast Neoplasms/enzymologyBreast Neoplasms/mortalityBreast Neoplasms/pathologyClinical Trials, Phase III as TopicDisease ProgressionDisease-Free SurvivalFemaleHumansNeoplasm MetastasisPhthalazines/adverse effectsPhthalazines/therapeutic usePiperazines/adverse effectsPiperazines/therapeutic usePoly(ADP-ribose) Polymerase Inhibitors/adverse effectsPoly(ADP-ribose) Polymerase Inhibitors/therapeutic useRandomized Controlled Trials as TopicTreatment Outcome
Substances： See more » PhthalazinesPiperazinesPoly(ADP-ribose) Polymerase Inhibitorsolaparib
Year: 2017 PMID： 28602780 DOI： 10.1016/S1470-2045(17)30453-9
Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316